Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

A Biochemist Reveals The One Tech That Could Revolutionize Drug Discovery

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.

Moderna's COVID Vaccine Sales Exceed Expectations in 2023!

Moderna's COVID Vaccine Sales Exceed Expectations in 2023!

In a stunning achievement, Moderna recently announced that their preliminary COVID vaccine sales for 2023 have met their target. This is fantastic news for...

11 Stocks Are Taking Off Already — And The Year Just Started

11 Stocks Are Taking Off Already — And The Year Just Started

The calendar just flipped to 2024 — and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Florida Surgeon General's Claims on COVID Vaccines Debunked as Nonsense

Explore the debunked claims made by the Florida State Surgeon General regarding COVID vaccines and the integration of contaminants into DNA in this insight...

Drugs of the future will be easier and faster to make, thanks to mRNA – after researchers work out a few remaining kinks

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

The Conversation

Covid jabs could be sold on the high street like flu vaccine

Boots and Superdrug have confirmed they are looking at ways to sell Covid vaccines from their high street stores

The Independent UK

FDA Spots Control Irregularities in Moderna's US Plant

Dive into the intriguing saga of unanticipated control failures at Moderna's magnate production plant, a juicy scoop exclusively unraveled by the meticulou...

inkl

Read news from The Economist, FT, and more,
with one subscription

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Dow Jones Closes Higher Amid 'Goldilocks' Setup; Moderna Soars On Cancer Vaccine

Dow Jones Closes Higher Amid 'Goldilocks' Setup; Moderna Soars On Cancer Vaccine

The Dow Jones rose to new highs after retail sales beat views while initial unemployment claims came in lower than expected. Moderna soared.

Investors Business Daily

Moderna Tests Promising Personalized Skin Cancer Vaccine with 49% Improvement!

Moderna Tests Promising Personalized Skin Cancer Vaccine with 49% Improvement!

Moderna tests a novel approach to battle skin cancer, with a vaccine showing benefits for melanoma patients. Treatment could be available by 2025.

Stocks and Bonds Continue Higher on Dovish Fed and Improved Soft-Landing Prospects

Stocks and Bonds Continue Higher on Dovish Fed and Improved Soft-Landing Prospects

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. Stocks this morning are mildly higher, with the S&P...

Stock Market Erases Gains As Indexes Stumble; Solar Stocks Shine

Stock Market Erases Gains As Indexes Stumble; Solar Stocks Shine

The Dow Jones index reached another high but the market weakened in afternoon trading. CAT stock jumped.

Investors Business Daily

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

International Business Times

Moderna Stock Soars On 'Transformational' Potential Of Its Merck-Tied Cancer Vaccine

Moderna Stock Soars On 'Transformational' Potential Of Its Merck-Tied Cancer Vaccine

Moderna's Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients. Moderna stock soared.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Customizing mRNA is easy, and that's what makes it the next frontier for personalized medicine − a molecular biologist explains

While using mRNA as medicine is new, mRNA has been inside you for your entire life. The cells in your body create mRNAs that serve as instructions to make specific proteins you need to function. Researchers can create new mRNAs to correct those instructions when they aren’t working.

Investors Business Daily

Moderna Stock Looks Sick; Here's How To Take Advantage With Options

Moderna stock has bounced off its 52-week low but still looks incredibly weak.

Should You Invest In IPOs? It's Still A Risky Prospect

Investing in IPOs may sound exciting, but it's often better to wait for newly public stocks to mature before buying.

The Conversation

What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday

Eli Lilly was an S&P 500 top performer Monday, while energy plays were among the day's biggest winners and losers.

Moderna’s CFO on the $25 billion innovation plan to work past the post-COVID slump

“There’s a true organic growth opportunity here,” Jamey Mock says.

Investors Business Daily

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat

Moderna stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.

Investors Business Daily

The Dreaded Market Crash Is Already Here For 14 Stocks

Investors fearing a brutal stock market crash are still waiting with dread. But it's already arrived for a group of battered S&P 500 stocks.

Why is Covid-19 Still Affecting the Healthcare Industry?

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

The Conversation

Beyond COVID vaccines: what else could mRNA technology do for our health?

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

Investors Business Daily

Stock Market Remains Steadfast; Data Analytics Stock Pops On Upgrade

The stock market remained positive with the major indexes all gaining around 1%. Retail stock rises on news it will get added to the S&P 500 Index.

People

Stephane Bancel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Bank of England

SP Global Market Intelligence

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

255,582 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play